1-1 of 1
Yashaswini Yeragunta, MD
Close
Sort by
Journal Articles

A Pilot Phase II Study of C-MOPP-R, Ibritumomab Tiuxetan, and Autologous Transplant for Untreated and Relapsed Follicular Lymphoma: Response, Toxicity, and Feasibility,

Mark J. Fesler, MD, Yashaswini Yeragunta, MD, Sheetal A. Majethia, MD, Paul J. Petruska, MD
Journal: Blood
Blood (2011) 118 (21): 4157.
https://doi.org/10.1182/blood.V118.21.4157.4157
Published: 2011